Effect of Tizanidine, Rilmenidine, and Yohimbine on Naloxon-Induced Morphine Withdrawal Syndrome in Mice

Valiollah Hajhashemi; Mohsen Minaiyan; Mohammad Seyedabadi

doi:10.22037/ijpr.2010.708

IJ Pharmaceutical Research

Current Issue All Issues In Press Accepted Manuscripts

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/ijpr.2010.708

Effect of Tizanidine, Rilmenidine, and Yohimbine on Naloxon-Induced Morphine Withdrawal Syndrome in Mice

Author(s):

Valiollah Hajhashemi^1,*,

Mohsen Minaiyan¹,

Mohammad Seyedabadi¹

1Department of Pharmacology and the Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

IJ Pharmaceutical Research:Vol. 6, issue 2; 115-121

Published online:Nov 20, 2010

Article type:Research Article

Received:Feb 21, 2006

Accepted:Jun 21, 2006

How to Cite:Hajhashemi V, Minaiyan M, Seyedabadi M. Effect of Tizanidine, Rilmenidine, and Yohimbine on Naloxon-Induced Morphine Withdrawal Syndrome in Mice. Iran J Pharm Res. 2022;6(2):e128319. doi: https://doi.org/10.22037/ijpr.2010.708

Abstract

In this study using clonidine (a mixed α₂ /I₁ receptors agonist), tizanidine (pure α₂-receptor agonist), rilmenidine (I₁ receptor agonist) and yohimbine (α₂-receptor antagonist), we tried to clarify the role of imidazoline and α₂-receptors in morphine withdrawal syndrome.

Morphine-dependence was induced by administration of increasing doses of morphine in mice. After the last administration of morphine, clonidine (0.3 mg/kg, i.p.), tizanidine (1 and 2 mg/kg, i.p.) and rilmenidine (1.5 and 3 mg/kg, i.p.), with / without pretreatment with yohimbine (1 mg/kg, i.p.) were administered 30 min before naloxone (5 mg/kg, i.p.) challenge. Withdrawal symptoms including: jumping, ptosis, piloerection, tremor and diarrhea were recorded.

Rilmenidine (3 mg/kg) decreased naloxone-induced jumping and this effect was partially inhibited by yohimbine. Rilmenidine (1.5 mg/kg), tizanidine and clonidine had no significant effect on jumping. None of drugs influenced ptosis. All drugs increased piloerection and decreased diarrhea. Clonidine and tizanidine decreased tremor.

We conclude that Imidazoline receptors as well as α₂ receptors are involved in morphine withdrawal symptoms and yohimbine as an α₂-antagonist can suppress at least some effects of imidazoline agonists. It is suggested that α₂-receptors are located down-stream to imidazoline receptors and their blockade can inhibit imidazoline effects.

Keywords

Clonidine Imidazoline receptors

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 5 days ago
Scopus by Title: 4
Last Update: 5 days ago
Scopus by Title (Ref): 0
Last Update: 5 days ago
CrossRef: 0
Last Update: 4 days ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Valiollah Hajhashemi:[PubMed][Scholar]
Mohsen Minaiyan:[PubMed][Scholar]
Mohammad Seyedabadi:[PubMed][Scholar]

Outlines

Effect of Tizanidine, Rilmenidine, and Yohimbine on Naloxon-Induced Morphine Withdrawal Syndrome in Mice

Abstract

Crossmark

Checking

Last Update: 5 days ago

Last Update: 5 days ago

Last Update: 5 days ago

Last Update: 4 days ago